Japan· JP-2122001X1010
キニジン硫酸塩水和物
A quinidine product containing キニジン硫酸塩水和物, registered in Japan, on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Quinidine is registered in 6 of 19 countries.
Countries holding a registration under ATC C01BA01 (quinidine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 3 of them publish a price we can compare per daily dose
Quinidine · ATC C01BA01
6 / 19 countries
- Finlandprice
- Japan
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- キニジン硫酸塩水和物
- Manufacturer
- —
- Country
- Japan (JP)
- ATC code
- C01BA01
- ATC class
- Quinidine
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
491 interactions on record for quinidine.
Graded by severity as the source publishes them — 135 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Quinidine · interactions on record
491 records
- 135 severe
- 198 moderate
- 8 minor
- 108 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
42 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Quinidine in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomKinidin 250mg DurulesAstraZeneca UK Ltd
- United StatesQuinidine gluconateEywa Pharma Inc
- FinlandChinidini SulfasOrion Corporation Orion Pharma
- NorwayQuinidine Sulfate epicEpic Pharma
- BelgiumNuedexta 15 mg - 9 mgJenson Pharmaceutical Services
- NetherlandsKinidinesulfaat Teva 200 mg, drageesTeva Nederland B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Hungary · Chinidin-Wagner
- Netherlands · Kinidinesulfaat Teva
- Romania · Chinidina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a7efc82b-1e96-46a9-8a03-e90c86ba4466 GET /v1/drugs/a7efc82b-1e96-46a9-8a03-e90c86ba4466?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１ｇ",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "2122001X1010",
"category": "内用薬",
"price_yen": null,
"generic_name": "キニジン硫酸塩水和物",
"product_name_jp": null,
"therapeutic_class": "2122",
"transitional_expiry": null
}See everything about quinidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.